A Guide to using BiFET

Introduction

BiFET (Bias-free Footprint Enrichment Test) aims to identify TFs whose footprints are over-represented in target regions compared to background regions after correcting for differences in read counts and GC contents between target and background regions, where regions represent ATAC-seq or DNAse-seq peaks. In this example, we used BiFET to detect TFs associated with cell-specific open chromatin regions by analyzing ATAC-seq data from human PBMCs (Ucar, et al., 2017) and pancreatic islets (Khetan, et al., 2017).

In order to use BiFET, the user will need an input file with two GRanges objects:

1. Obtaining a Peak File

# Load necessary libraries
suppressPackageStartupMessages(library(BiFET))
suppressPackageStartupMessages(library(GenomicRanges))
library(BiFET)
library(GenomicRanges)
peak_file <- system.file("extdata", "input_peak_motif.Rdata",
                         package = "BiFET")
load(peak_file)

# Display the first few rows and columns of the peak file
head(GRpeaks)

In this example, the file input_peak_motif.Rdata was obtained as follows: we used ATAC-seq data obtained from five human PBMC (Ucar, et al., 2017) and five human islet samples (Khetan, et al., 2017) and called peaks using MACS version 2.1.0 (Zhang, et al., 2008) with parameters -nomodel -f BAMPE. The peak sets from all samples were merged to generate one consensus peak set (N = 57,108 peaks) by using R package DiffBind_2.2.5. (Ross-Innes, et al., 2012), where only the peaks present at least in any two samples were included in the analysis. We used the summits option to re-center each peak around the point of greatest enrichment and obtained consensus peaks of same width (200bp).

Out of these consensus peaks, we defined regions that are specifically accessible in PBMC samples as regions where at least 4 PBMC samples have a peak, whereas none of the islet samples have a peak (n=4106 peaks; these regions are used as target regions in this example). Similarly, we defined islet-specific peaks as those that were called as a peak in at least 4 islet samples but none in any of the PBMC samples (n=12886 peaks). The rest of the peaks excluding the PBMC/islet-specific peaks were used as the background (i.e., non-specific) peaks in our analyses (n=40116 peaks). For each peak, GC content was obtained using peak annotation program annotatePeaks.pl from the HOMER software (Heinz. et al., 2010).

2. Obtaining a Matrix of Footprint Calls

# Display the first few rows and columns of the motif file
head(GRmotif)

In this example, TF footprints were called using PIQ algorithm (Sherwood, et al., 2014) using the pooled islet samples and pooled PBMC samples to increase the detection power for TF footprints. We used only the TF footprints that have a purity score greater than 0.9. The example file contains footprint calls for only five PWMs from the JASPAR database to reduce computing time.

3. Calculating enrichment p-value

The function calculate_enrich_p calculates p-value testing if footprints of a TF are over-represented in the target set of peaks compared to the background set of peaks correcting for the bias arising from the imbalance of GC-content and read counts between target and background set. The function requires two GRanges objects as input parameters: GRpeaks and GRmotif.

# call the function “calculate_enrich_p” to return a list of 
# parameter alpha_k, enrichment p values from BiFET algorithm 
  # and enrichment p values from the hypergeometric test :
result <- calculate_enrich_p(GRpeaks, GRmotif)
head(result)

Citing BiFET

BiFET: A Bias-free Transcription Factor Footprint Enrichment Test, Ahrim Youn, Eladio J Marquez, Nathan Lawlor, Michael L Stitzel, Duygu Ucar, bioRxiv 2018:324277 (https://www.biorxiv.org/content/early/2018/05/16/324277)


References

  1. Khetan, S., et al. Chromatin accessibility profiling uncovers genetic-and T2D disease state-associated changes in cis-regulatory element use in human islets. bioRxiv 2017:192922.

  2. Ross-Innes, C.S., et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012;481(7381):389-393.

  3. Ucar, D., et al. The chromatin accessibility signature of human immune aging stems from CD8+ T cells. Journal of Experimental Medicine 2017;jem 20170416.

  4. Sherwood, et al. Discovery of Directional and Nondirectional Pioneer Transcription Factors by Modeling DNase Profile Magnitude and Shape. Nature Biotechnology 32, no. 2 (February 2014): 171.

  5. Heinz, et al. Simple Combinations of Lineage-Determining Transcription Factors Prime Cis-Regulatory Elements Required for Macrophage and B Cell Identities. Molecular Cell 38, no. 4 (May 28, 2010): 576–89.

  6. Zhang, et al. Model-Based Analysis of ChIP-Seq (MACS). Genome Biology 9 (2008): R137.

  7. Ross-Innes, et al. Differential Oestrogen Receptor Binding Is Associated with Clinical Outcome in Breast Cancer. Nature 481, no. 7381 (January 19, 2012): 389–93.



Try the BiFET package in your browser

Any scripts or data that you put into this service are public.

BiFET documentation built on Nov. 8, 2020, 11 p.m.